IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q4 2015 Holdings

Filed 2016-02-12 | 21 holdings | $17.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Coherus Biosciences Inc(CHRS)COM19249H103$14.0M611,01080.7%
Ascendis Pharma A/S(ASND)COM04351P101$1.6M90,0009.5%
CytomX Therapeutics Inc(CTMX)COM23284F105$1.6M75,0009.0%
DBV TechnologiesCOMF2927N109$32.5K463,6430.2%
Heron Therapeutics Inc(HRTX)COM427746102$29.3K1,095,7340.2%
GW PharmaceuticalsCOM36197T103$21.7K311,8530.1%
Anacor Pharmaceuticals IncCOM032420101$15.9K140,7560.1%
Lipocine IncCOM53630X104$11.0K849,9210.1%
Avalanche Biotechnologies IncCOM05337G107$10.5K1,102,7350.1%
Flamel Technologies S.A.COM338488109$6.1K500,0000.0%
Zafgen IncCOM98885E103$3.4K541,4800.0%
Alcobra LtdCOMM2239P109$3.0K484,5000.0%
Akari Therapeutics PlcCOM00972G108$2.3K158,3520.0%
Ocera TherapeuticsCOM67552A108$2.2K703,7300.0%
Arca biopharma IncCOM00211Y100$2.2K462,3990.0%
Global Blood TherapeuticsCOM37890U108$2.0K60,6910.0%
Cynapsus Therapeutics IncCOM23257Y701$1.7K110,2260.0%
Edge Therapeutics IncCOM279870109$1.7K135,0000.0%
ProNAI Therapeutics IncCOM74346L101$1.1K75,0000.0%
Regenxbio Inc(RGNX)COM75901B107$87252,5000.0%
Stemline Therapeutics IncCOM85858C107$855135,4200.0%